- Home
- CSGS vs BCRX Comparison
CSGS vs BCRX Comparison
Compare CSGS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- BCRX
- Stock Information
- Founded
- CSGS 1994
- BCRX 1986
- Country
- CSGS United States
- BCRX United States
- Employees
- CSGS N/A
- BCRX N/A
- Industry
- CSGS EDP Services
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSGS Technology
- BCRX Health Care
- Exchange
- CSGS Nasdaq
- BCRX Nasdaq
- Market Cap
- CSGS 1.9B
- BCRX 1.9B
- IPO Year
- CSGS 1996
- BCRX 1994
- Fundamental
- Price
- CSGS $60.77
- BCRX $7.95
- Analyst Decision
- CSGS Buy
- BCRX Strong Buy
- Analyst Count
- CSGS 8
- BCRX 10
- Target Price
- CSGS $68.29
- BCRX $16.70
- AVG Volume (30 Days)
- CSGS 235.5K
- BCRX 3.2M
- Earning Date
- CSGS 08-06-2025
- BCRX 08-04-2025
- Dividend Yield
- CSGS 2.11%
- BCRX N/A
- EPS Growth
- CSGS 33.32
- BCRX N/A
- EPS
- CSGS 2.92
- BCRX N/A
- Revenue
- CSGS $1,201,566,000.00
- BCRX $503,485,000.00
- Revenue This Year
- CSGS $3.32
- BCRX $37.96
- Revenue Next Year
- CSGS $3.56
- BCRX $8.82
- P/E Ratio
- CSGS $20.79
- BCRX N/A
- Revenue Growth
- CSGS 3.08
- BCRX 41.67
- 52 Week Low
- CSGS $42.47
- BCRX $6.02
- 52 Week High
- CSGS $67.60
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- CSGS 38.41
- BCRX 27.72
- Support Level
- CSGS $61.44
- BCRX $8.02
- Resistance Level
- CSGS $63.08
- BCRX $8.39
- Average True Range (ATR)
- CSGS 1.22
- BCRX 0.27
- MACD
- CSGS -0.11
- BCRX -0.02
- Stochastic Oscillator
- CSGS 5.97
- BCRX 3.51
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.